Global Tissue Engineering Market is Expanding Owing to Growing Prevalence of Orthopedic Disorders and Growing Product Launches


Overview

Tissue engineering involves reprogramming somatic cells and using scaffolds to engineer new tissue, which can be used to replace or repair damaged tissues. The tissue can be made from stem cells or other cell types. Tissues are created in the lab by growing them from stem cells on a scaffold, which is a three-dimensional structure that mimics the environment of the body and provides conditions for the stem cells to grow into the tissue. Scaffolds are also designed to be biocompatible, meaning they don't damage the tissues they touch. Stem cells are a key element of tissue engineering as they have the ability to differentiate into many different types of tissues, including bones, cartilages, adipose, blood vessels and nerves. They can also help repair damaged tissue by removing dead cells and encouraging regeneration of the new tissue. The most common type of stem cell is the embryonic hematopoietic stem cell (HSC) that is found in bone marrow. Other types of stem cells, such as mesenchymal stem cells (MSC), have also been used in tissue engineering.

Market Dynamics:

Growing product launches are estimated to augment growth of the global engineering market during the forecast period. For instance, a new endotoxin-controlled, pharmaceutical-grade gelatin Quali-Pure HGP 2000, was launched by Rousselot, Darling Ingredients’ in May 2022. This has been specially designed for wound healing and vaccines. Moreover, lack of biomaterials and techniques are anticipated to restrain growth of the global tissue engineering market during the forecast period.

Global Tissue Engineering Market is estimated to be valued at US$ 9,436.0 million in 2022 and is expected to exhibit a CAGR of 11.7% during the forecast period (2022-2030).

Impact of COVID-19:


The pandemic was first reported in 2019 and in 2020 it was declared as a global health emergency by the WHO. The pandemic impacted the growth activities of many sectors. Several industries were facing shortages of resources and owing to that manufacturing activities were halted. The pandemic also impacted the research and developmental activities sin many sectors. As there was a shortage of resources for conducting scientific research. All rwsoyrces were used for developing drugs and vaccines for battling COVID-19. This hampered the growth of the global Tissue Engineering Market during the pandemic.

Key Takeaways:

The global tissue market is estimated to witness significant growth, exhibiting CAGR of 11.7 % during the forecast period, due to increasing acquisitions by key players. For instance, D Systems, acquired a German software company Additive Works GmbH, in May 2021. This acquisition will improve their simulation capabilities and also speed up the processes for large-scale 3D printing.

North America is anticipated to witness significant growth in the global tissue market during the forecast period, owing to rising awareness regarding stem cell therapy and increasing geriatric population.

Key players active in the global tissue engineering market are Integra Lifescience, B. Braun Melsungen AG, Tissue Regenix Group plc, ReproCell, Inc., Zimmer Biomet, Athersys, Inc., RTI Surgical, Inc., Medtronic plc, Allergan plc, Integra LifeSciences Corporation, ACell, Inc., and Organogenesis Holdings Inc.


Comments

Popular posts from this blog

Refinery Catalysts are Important Components of a Petroleum Refinery

Wearable Injector are Devices Which Adhere to the Body and Help in Administering Drug to the Patient

Global Flocculant And Coagulant Market Is Estimated To Witness High Growth Owing To Increasing Demand For Water Treatment Applications